Hospital management of heart failure: improvement but still room for improvement at discharge...
Cohen-Solal
A
A
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D004032:Diet; D004232:Diuretics / Q000627:therapeutic use; D004363:Drug Utilization; D005602:France / Q000453:epidemiology; D006333:Heart Failure / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D017052:Hospital Mortality; D006760:Hospitalization; D006772:Hospitals, Military; D006801:Humans; D008019:Life Style; D020097:Natriuretic Peptide, Brain / Q000097:blood; D010353:Patient Education as Topic; D010359:Patient Readmission / Q000706:statistics & numerical data; D010446:Peptide Fragments / Q000097:blood; D011785:Quality Assurance, Health Care; D013148:Spironolactone / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D047228:Angiotensin II Type 1 Receptor Blockers; D004232:Diuretics; D010446:Peptide Fragments; C109794:pro-brain natriuretic peptide (1-76); D020097:Natriuretic Peptide, Brain; D013148:Spironolactone